Insys Therapeutics (NASDAQ:INSY) Earnings History and Estimates Chart
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Insys Therapeutics (NASDAQ:INSY) Earnings Estimates
Current Year EPS Consensus Estimate: $-1.55 EPS
Next Year EPS Consensus Estimate: $-0.88 EPS
Insys Therapeutics (NASDAQ INSY) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
11/4/2019
(Estimated) | | | | | | | | |
| 5/10/2019 | 3/31/2019 | ($0.22) | ($0.55) | $0.50 | $14.95 million | $7.63 million | N/A | |
| 3/7/2019 | 12/31/2018 | ($0.29) | ($0.37) | ($0.16) | $17.93 million | $16.36 million | Transcript | |
| 11/5/2018 | 9/30/2018 | ($0.32) | ($0.40) | ($0.39) | $24.05 million | $18.30 million | N/A | |
| 8/8/2018 | Q2 2018 | ($0.16) | ($0.33) | ($0.37) | $25.91 million | $23.47 million | N/A | |
| 5/8/2018 | Q1 2018 | ($0.18) | ($0.19) | ($0.16) | $25.82 million | $23.90 million | N/A | |
| 3/8/2018 | Q4 2017 | ($0.14) | ($0.61) | $0.19 | $34.00 million | $31.49 million | Transcript | |
| 11/2/2017 | Q3 2017 | ($0.23) | ($0.25) | $1.80 | $34.98 million | $30.67 million | N/A | |
| 8/3/2017 | Q2 2017 | ($0.09) | $0.03 | $0.09 | $36.90 million | $42.60 million | Listen | |
| 5/9/2017 | Q1 2017 | ($0.10) | ($0.09) | ($0.09) | $37.78 million | $35.92 million | Listen | |
| 4/3/2017 | Q4 2016 | ($0.0020) | $0.03 | $0.03 | $52.08 million | $54.86 million | N/A | |
| 11/3/2016 | Q316 | $0.02 | $0.07 | | $55.97 million | $55.20 million | N/A | |
| 8/3/2016 | Q216 | $0.07 | $0.06 | $0.06 | $66.90 million | $67.10 million | Listen | |
| 4/28/2016 | Q116 | $0.07 | $0.11 | $0.03 | $61.31 million | $62.00 million | Listen | |
| 2/23/2016 | Q415 | $0.29 | $0.36 | $0.22 | $91.04 million | $91.10 million | Listen | |
| 11/5/2015 | Q315 | $0.23 | $0.50 | $0.34 | $82.98 million | $91.30 million | N/A | |
| 8/6/2015 | Q215 | $0.21 | $0.16 | $0.22 | $74.06 million | $77.60 million | N/A | |
| 5/7/2015 | Q115 | $0.40 | $0.63 | $0.41 | $70.90 million | $70.80 million | N/A | |
| 3/3/2015 | Q414 | $0.44 | $0.53 | $0.13 | $63.50 million | $66.50 million | N/A | |
| 11/11/2014 | Q314 | $0.29 | $0.63 | $0.38 | $57.10 million | $58.30 million | N/A | |
| 8/12/2014 | Q214 | $0.30 | $0.48 | $0.35 | $52.77 million | $55.70 million | N/A | |
| 5/13/2014 | Q1 2014 | $0.14 | $0.18 | $0.25 | $46.00 million | $41.64 million | N/A | |
| 3/4/2014 | Q4 2013 | $0.18 | $0.21 | $0.08 | $34.73 million | $40.20 million | N/A | |
| 11/12/2013 | Q3 2013 | $0.11 | $0.17 | $0.17 | $27.00 million | $29.20 million | Listen | |
| 8/13/2013 | Q2 2013 | $0.05 | $0.09 | $0.09 | $15.07 million | $18.80 million | N/A | |
| 6/3/2013 | Q113 | | $0.01 | | $2.00 million | $11.10 million | N/A | |
| 8/26/2010 | Q2 2010 | | ($0.59) | ($0.59) | | | N/A | |
| 6/11/2010 | Q1 2010 | | ($1.02) | ($1.02) | | | N/A | |
| 3/18/2010 | Q4 2009 | | ($0.33) | $0.42 | | | N/A | |
| 10/26/2009 | Q3 2009 | | ($1.26) | ($1.26) | | | N/A | |
| 7/27/2009 | Q2 2009 | | ($1.42) | ($1.42) | | | N/A | |
| 4/28/2009 | Q1 2009 | | ($1.61) | ($1.61) | | | N/A | |
| 3/4/2009 | Q4 2008 | | ($1.59) | ($1.59) | | | N/A | |
| 11/12/2008 | Q3 2008 | | ($1.71) | ($1.71) | | | N/A | |
| 8/14/2008 | Q2 2008 | | ($1.48) | ($1.48) | | | N/A | |
| 5/12/2008 | Q1 2008 | | ($1.08) | ($1.08) | | | N/A | |
| 3/27/2008 | Q4 2007 | | ($0.75) | ($0.75) | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
